ARCHIVES

NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms

This article is from The Cancer Letter archive.

Vol. 06 No. 06 | February 8, 1980

Download PDF Visit The Full Archive

Related Articles

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

May 31, 2013

Cancer Screenings: American Over 50 Urged to Get Colon Caner Tests

March 5, 1999

NCI Cooperative Group Clinical Trials Approved

October 29, 2010

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

NCI Cooperative Group, Cancer Center Trials Listed

August 29, 2008

Biomarker May Predict Prostate Cancer Metastases

December 27, 2013